Seneca Partners
Seneca Partners is an award-winning specialist SME investment and advisory business. Formed in 2010, and headquartered in the North West of England, the management team have extensive experience across a range of sectors, including private equity, corporate finance, wealth management, accountancy and stockbroking. Seneca won “Alternative Finance Provider” in both 2016 and 2017 at the North West Business Insider Awards. Seneca Partners is also the founding member of the Seneca branded network of companies which includes Seneca Investment Managers, a Liverpool based fund manager with more than £500 million under management, Seneca Finance Limited, a property bridging finance provider with a loan book of more than £20 million and Seneca Property Investments Limited who have more than £50 million of commercial property investments under their management. This wider Seneca branded network of companies operates from 5 offices across the North of England and employs more than 60 people.
Sector
17 past transactions
HubBox
Venture Round in 2023
HubBox is the first universal Click & Collect solution for online retailers. Their market-leading software means that any retailer can strengthen their delivery proposition by offering local Click & Collect and in-store pick up at checkout.
Their software powers Click & Collect for hundreds of retailers, including brands such as Boohoo, Whistles, hmv, Warehouse and TM Lewin.
Apex Molecular
Venture Round in 2016
Apex Molecular Ltd provides specialist chemistry services to pharmaceutical, biotechnology (life sciences), and applied chemistry sectors. The company offers laboratory-scale chemistry development services, including high potency synthesis, custom/contract synthesis, and development and scale-up. Its customers include drug discovery, biotechnology, and agritech companies. The company was formerly known as YProTech Ltd. and changed its name to Apex Molecular Ltd in 2019. Apex Molecular Ltd was incorporated in 2008 and is based in Alderley Edge, United Kingdom.
Sorted Holdings Limited
Venture Round in 2016
Sorted Holdings Limited operates as a software as a service (SaaS) company. The Company offers delivery platform for online checkouts, warehouses, shipping, carrier management, shipping, delivery tracking, and post-purchase experience. It has products such as SortedHERO which provides real time delivery option data checkout services, SortedPRO which connects to carrier services with scalable delivery management, and SortedREACT which is carrier tracking platform. The company serves customers worldwide. Sorted Holdings Limited was founded in 2010 and is based in Manchester, United Kingdom.
SolasCure Limited
Series A in 2021
SolasCure Limited develops Aurase, a hydrogel for patients with chronic wounds. The company’s product offers wound debridement, a therapeutic procedure where dead, damaged, or infected tissue is removed to improve wound healing. The company was founded in 2017 and is based in Wales, United Kingdom.
W.S. Rothband & Co
Acquisition in 2015
W.S. Rothband & Co Ltd. manufactures and sells lead aprons for radiology environments in Europe and the Middle East. It offers radiology products; lead apron repairs and associated products, such as lead apron storage solutions, lead protective screens and shields, structural shielding, lead curtains, and others. Its product categories include bone densitometry scanners, cassette holders/grids/markers, couches/steps/stools, darkroom and processing areas, DICOM tools, digital products, film filing and storage products, filters, infection control products, mammography, MRI furniture and accessories, patient procedure products, phantoms/teaching products, quality assurance products, radiation protection products, and ultrasound products. The company was founded in 1860 and is based in Rossendale, United Kingdom.
Gelmetix
Series C in 2021
Gelmetix Limited develops injectable gel-based therapeutic biomaterial medical devices for bone disorders and early-stage degenerative disc disease. The company offers microgel therapy for chronic low back pain, small joints osteoarthritis, and knee osteoarthritis. The company was formerly known as Gelexir Healthcare Ltd and changed its name to Gelmetix Limited in July 2018. Gelmetix Limited was founded in 2012 and is based in Nether Alderley, United Kingdom with additional offices in London and Manchester, United Kingdom; and Paris, France.
23.5 Degrees Limited
Venture Round in 2015
23.5 Degrees Limited was Starbucks’ first franchisee globally. Having opened our first store in February 2013, 23.5 Degrees currently operates 42 stores with a current pipeline of 35 further stores approved and under development. We have a developmental territory covering Oxfordshire, Berkshire, Hampshire, Wiltshire, Cambridgeshire, Norfolk, Hertfordshire, Essex, Dorset in the South and East Anglia as well as Lancashire, Yorkshire, Cumbria and Northumberland in the North of England. Managing Director, Mark Hepburn, has a track record of significant success in food service franchise businesses, including Burger King and KFC and our business growth is supported by private equity firm Connection Capital as well as RBS.
Fabacus Holdings Limited
Seed Round in 2019
Fabacus Holdings Limited develops Xelacore, a platform that connects licensors, licensees, agents, and retailers by providing visibility and control of the supply chain process. The company was incorporated in 2013 and is based in London, United Kingdom.
Gelmetix
Series C in 2020
Gelmetix Limited develops injectable gel-based therapeutic biomaterial medical devices for bone disorders and early-stage degenerative disc disease. The company offers microgel therapy for chronic low back pain, small joints osteoarthritis, and knee osteoarthritis. The company was formerly known as Gelexir Healthcare Ltd and changed its name to Gelmetix Limited in July 2018. Gelmetix Limited was founded in 2012 and is based in Nether Alderley, United Kingdom with additional offices in London and Manchester, United Kingdom; and Paris, France.
SkinBioTherapeutics Plc
Post in 2018
SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. The company focuses on the development of SkinBiotix technology for use in cosmetic, infection control, and eczema applications. It has an agreement with Croda International Plc for the design and manufacture of a new active cosmetic skincare ingredient based on its SkinBiotix skin microbiome technology. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Macclesfield, the United Kingdom.
Bright
Series B in 2020
Bright Network operates a social recruitment site for graduates and young professionals. The company was formerly known as Bright London (UK) Limited. It was incorporated in 2007 and is based in London, United Kingdom.
Redx Pharma Plc
Post in 2017
Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in the areas of cancer, infection and autoimmune disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.
Redx Pharma has three subsidiaries: Redx Oncology Ltd launched in April 2012, Redx Anti-Infectives Ltd launched in April 2013 and Redx Immunology Ltd launched in May 2015.
Inc. Travel Group.
Venture Round in 2016
Inc. Travel Group exist to positively shape your travel experience by using our insights.
Vizibl
Series A in 2019
We build software that enables Enterprises to forge deeper and more valuable relationships with their Buyers and Suppliers.
Our products and platforms increase innovation, collaboration, alignment and agility. Decrease risks, costs, duplication and time to action. And they improve processes, productivity, accountability and connections.
We call it ‘Enterprise Level Innovation’.
appScatter
Venture Round in 2017
Appscatter Limited develops and operates distribution platform for mobile application developers. It offers appScatter, a scalable B2B SaaS platform that allows paying users to distribute their apps to, and manage their apps on, multiple app stores. The company’s centralized platform enables app developers and publishers to manage and track performance of their own and competing apps across all of the app stores on the platform. The company was founded in 2015 and is based in London, United Kingdom.
The Hook Group
Private Equity Round in 2019
The Hook Group has rapidly grown into one of the worlds leading media groups dominating the shift to social.
Made up of two divisions:
1. Marketing - The Hook Labs: Voted the UK's #1 Social Marketing Agency, The Hook Labs scales brands and makes them famous on social, through a combination of social first content, influencer marketing and its distribution network of over 1bn people. It is a market leader in scaling social commerce sales.
2. Media - The Hook: Rapidly grown into one of the largest youth entertainment channels on social, with an asset based of 12.7m followers. Focussed on pop culture, it creates and curates content that makes its fan laugh or be inspired - from funny interviews with Hollywood actors to inspiring mini-docs about great athletes.
Gelmetix
Series B in 2018
Gelmetix Limited develops injectable gel-based therapeutic biomaterial medical devices for bone disorders and early-stage degenerative disc disease. The company offers microgel therapy for chronic low back pain, small joints osteoarthritis, and knee osteoarthritis. The company was formerly known as Gelexir Healthcare Ltd and changed its name to Gelmetix Limited in July 2018. Gelmetix Limited was founded in 2012 and is based in Nether Alderley, United Kingdom with additional offices in London and Manchester, United Kingdom; and Paris, France.